V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250008204 | 250005628 | null | 73 | Palliative (P) | 2017-08-25 | 2017-08-25 | Temozolomide 150mg/m2 | N | N | 250020344 | IPM |
| 250008205 | 250005628 | 1.57 | null | Palliative (P) | 2017-10-15 | 2017-10-22 | DA 3 + 10 | N | N | 250020344 | RITUXIMAB |
| 250008206 | 250005629 | 1.69 | 29.3 | Disease modification (D) | 2014-08-17 | 2014-08-17 | DA 3 + 10 | N | N | 250020418 | TRIAL |
| 250008207 | 250009945 | null | null | Palliative (P) | 2017-11-20 | 2017-11-20 | Pemetrexed | 02 | N | 250020498 | BORTEZOMIB |
| 250008208 | 250009945 | 1.78 | 63.5 | Palliative (P) | 2014-02-12 | 2014-02-15 | EOX | N | N | 250020498 | GEMCARBO |
| 250008209 | 250005630 | 1.78 | 66.4 | Disease modification (D) | 2017-01-27 | 2017-03-02 | Sorafenib | N | N | 250020833 | CAPECITABINE + OXALIPLATIN |
| 250008210 | 250005631 | 1.82 | null | Palliative (P) | 2017-08-27 | 2017-09-10 | Vinorelbine IV | N | null | 250020907 | TRIAL |
| 250008211 | 250009946 | 1.69 | 59.6 | Palliative (P) | null | 2014-02-05 | Cisplatin | null | null | 250020978 | IPM |
| 250008212 | 250009946 | 1.8 | 69 | Adjuvant (A) | 2017-05-16 | 2017-05-16 | Not Chemo + Hydroxocobalamin | N | N | 250020978 | RUXOLITINIB |
| 250008213 | 250005632 | 1.7 | null | Palliative (P) | 2018-10-16 | 2018-10-16 | IPM | 02 | N | 250020985 | CARBOPLATIN + ETOPOSIDE |
| 250008214 | 250005632 | 1.76 | null | null | 2017-12-26 | 2017-12-29 | BENDAMUSTINE + RITUXIMAB | N | N | 250020985 | DA |
| 250008215 | 250005633 | 1.49 | 80 | Curative (C) | null | 2014-10-12 | MESO-02 TRIAL | N | N | 250021139 | CHOP R |
| 250008216 | 250005633 | 1.68 | 79.8 | Palliative (P) | null | 2017-08-24 | IPM | N | N | 250021139 | IPM |
| 250008217 | 250005634 | null | 78.1 | Palliative (P) | 2016-05-23 | 2016-05-25 | Pemetrexed | null | null | 250021291 | CHOP R |
| 250008218 | 250005635 | null | 64 | Curative (C) | 2014-01-29 | 2014-01-29 | STAMPEDE TRIAL | 01 | null | 250021714 | SUNITINIB |
| 250008219 | 250009949 | 1.67 | 89.9 | Disease modification (D) | null | 2017-06-26 | Trial Unspecified | N | N | 250021813 | TRIAL |
| 250008220 | 250005636 | 1.7 | 65.1 | Palliative (P) | 2014-05-12 | 2014-05-12 | CARBOPLATIN + ETOPOSIDE | N | N | 250021867 | NOT MATCHED |
| 250008221 | 250005636 | 1.58 | null | Palliative (P) | 2017-03-25 | 2017-03-25 | RUXOLITINIB | 1 | N | 250021867 | BUSULPHAN |
| 250008222 | 250005636 | 1.67 | 0 | Adjuvant (A) | 2017-10-18 | 2017-10-24 | GemCarbo Days 1+8 | N | N | 250021867 | CARBOPLATIN |
| 250008223 | 250005637 | 1.7 | null | Palliative (P) | 2018-05-06 | 2018-05-21 | IPM | N | N | 250022714 | VINORELBINE |
| 250008224 | 250005637 | 1.8 | 70.4 | Curative (C) | 2015-05-26 | 2015-05-26 | MESO-02 TRIAL | 02 | N | 250022714 | CARBOPLATIN + ETOPOSIDE |
| 250008225 | 250005637 | 1.89 | 81.8 | Disease modification (D) | null | 2017-12-30 | Vinorelbine IV | N | N | 250022714 | TRIAL |
| 250008226 | 250005638 | null | 76.8 | null | 2014-09-12 | 2014-09-13 | Cisplatin + Paclitaxel | 02 | N | 250023894 | DA |
| 250008227 | 250005639 | null | 50.6 | Curative (C) | 2018-07-23 | 2018-07-24 | Pemetrexed | N | N | 250024308 | DA |
| 250008228 | 250005640 | 1.74 | 57.9 | Disease modification (D) | 2018-05-06 | 2018-06-02 | Docetaxel | N | N | 250024343 | VINORELBINE |
| 250008229 | 250009952 | 1.78 | 0 | Disease modification (D) | 2014-02-07 | 2014-02-16 | Capecitabine + Oxaliplatin 14day | N | N | 250024762 | NOT MATCHED |
| 250008230 | 250005641 | 1.75 | null | Disease modification (D) | 2017-12-28 | 2017-12-28 | Trial Unspecified | 02 | N | 250024774 | CISPLATIN + GEMCITABINE |
| 250008231 | 250005642 | null | 67 | null | 2016-01-25 | 2016-01-26 | Pemetrexed | 2 | N | 250024795 | TRIAL |
| 250008232 | 250005643 | 0 | 79.6 | Disease modification (D) | 2017-04-19 | 2017-04-19 | Cisplatin | 2 | N | 250024904 | TRIAL |
| 250008233 | 250005644 | 1.78 | 73.8 | Palliative (P) | 2017-09-08 | 2017-09-29 | Trial Unspecified | Y | N | 250025195 | CARBOPLATIN |
| 250008234 | 250005645 | null | 0 | Palliative (P) | 2014-08-05 | 2014-08-09 | FLAIR Trial | 2 | Y | 250025293 | PEMBROLIZUMAB |
| 250008235 | 250005646 | 0 | 0 | Palliative (P) | 2015-03-25 | 2016-09-19 | Pemetrexed | N | N | 250025676 | TRIAL |
| 250008236 | 250005647 | 1.6 | 76.45 | null | 2018-02-28 | 2018-03-04 | FLAG | null | N | 250025862 | CISPLATIN + GEMCITABINE |
| 250008237 | 250005647 | 1.57 | 69.4 | Neo-adjuvant (N) | 2016-04-05 | 2018-07-06 | Docetaxel | N | N | 250025862 | CARBOPLATIN + ETOPOSIDE |
| 250008238 | 250005647 | null | null | Palliative (P) | 2014-10-22 | 2014-10-29 | Rituximab | N | N | 250025862 | TRIAL |
| 250008239 | 250005647 | 1.63 | null | Palliative (P) | 2013-05-12 | 2013-05-12 | FEC | 2 | N | 250025862 | CHOP R |
| 250008240 | 250005647 | 0 | 77.4 | Palliative (P) | 2014-05-09 | 2014-06-27 | Cisplatin + Paclitaxel | N | N | 250025862 | TRIAL |
| 250008241 | 250005647 | 1.81 | null | Palliative (P) | 2015-06-24 | 2015-07-19 | Trial Unspecified | null | null | 250025862 | RUXOLITINIB |
| 250008242 | 250005648 | null | 68 | Palliative (P) | 2017-09-01 | 2017-09-01 | Cisplatin | 02 | N | 250027093 | VINORELBINE |
| 250008243 | 250009954 | null | 99 | Disease modification (D) | 2016-10-03 | 2016-10-03 | Gemcitabine weekly | 02 | N | 250027253 | PEMETREXED |
| 250008244 | 250009954 | 1.52 | 92.8 | Curative (C) | null | 2015-10-31 | Trial Unspecified | N | N | 250027253 | SCOT TRIAL |
| 250008245 | 250005649 | 1.56 | 0 | Palliative (P) | 2014-12-05 | 2014-12-05 | Pemetrexed | N | N | 250027278 | RUXOLITINIB |
| 250008246 | 250005650 | 0 | 0 | Palliative (P) | 2018-10-25 | 2018-10-25 | CARBOPLATIN | N | N | 250027449 | PEMETREXED |
| 250008247 | 250005650 | 1.55 | 74.2 | Palliative (P) | 2014-04-11 | 2014-04-24 | Carboplatin AUC 6 - 10 | 2 | N | 250027449 | BORTEZOMIB |
| 250008248 | 250005650 | null | 76.2 | Palliative (P) | 2018-12-03 | 2018-12-03 | Trial Unspecified | 02 | null | 250027449 | CISPLATIN + GEMCITABINE |
| 250008249 | 250005650 | 0 | null | Palliative (P) | null | 2014-07-26 | Trial Unspecified | N | N | 250027449 | VINORELBINE |
| 250008250 | 250005651 | null | 105.6 | Disease modification (D) | 2014-05-18 | 2014-06-09 | Vinorelbine IV | N | N | 250028595 | PEMETREXED |
| 250008251 | 250005651 | null | null | Curative (C) | 2018-07-21 | 2018-08-05 | DA 3 + 10 | N | N | 250028595 | GEMCARBO |
| 250008252 | 250005652 | null | null | Curative (C) | 2015-03-06 | 2015-03-06 | Paclitaxel+Trastuzumab wkly Maint | 02 | N | 250029279 | CISPLATIN + PACLITAXEL |
| 250008253 | 250005653 | 1.67 | 70 | Curative (C) | 2016-08-22 | 2016-09-05 | Trial Unspecified | 2 | N | 250029468 | FLAG + IDARUBICIN |